Mon, January 24, 2011
Sun, January 23, 2011
Sat, January 22, 2011
Fri, January 21, 2011
Thu, January 20, 2011
Wed, January 19, 2011
Tue, January 18, 2011
Mon, January 17, 2011
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
ICON Acquires Oxford Outcomes
Thu, January 13, 2011
Wed, January 12, 2011
Tue, January 11, 2011
Mon, January 10, 2011
[ Mon, Jan 10th 2011 ] - Market Wire
Teleflex Acquires VasoNova Inc.
[ Mon, Jan 10th 2011 ] - Market Wire
30 A.M. ET
Sun, January 9, 2011
Fri, January 7, 2011
Thu, January 6, 2011
Wed, January 5, 2011
Tue, January 4, 2011
Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010

AngioDynamics to Present at the 29th Annual J.P. Morgan Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. 9th-annual-j-p-morgan-healthcare-conference.html
Published in Health and Fitness on Friday, January 7th 2011 at 5:26 GMT by Market Wire   Print publication without navigation


ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 29th Annual J.P. Morgan Healthcare Conference at 2 p.m. PT on Thursday, January 13, 2011, at the Westin St. Francis Hotel in San Francisco, Calif. Jan Keltjens, President and Chief Executive Officer of AngioDynamics, will review the Companya™s business strategy and recent corporate developments.

A live webcast of AngioDynamicsa™ presentation may be accessed through the investor relations section of the Companya™s Web site at [ http://investors.angiodynamics.com ], where an archived replay of the presentation also will be available for 90 days after the live presentation.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].


Publication Contributing Sources